224 related articles for article (PubMed ID: 17002842)
21. [Medullary carcinoma of the thyroid: diagnosis and therapy].
Giuffrida D; Ferraù F; Bordonaro R; Mattina M; Priolo D; Aiello RA; Cordio S; Motta S; Failla G
Clin Ter; 2000; 151(1):29-35. PubMed ID: 10822879
[TBL] [Abstract][Full Text] [Related]
22. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
23. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
Shaha AR; Cohen T; Ghossein R; Tuttle RM
Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
[TBL] [Abstract][Full Text] [Related]
24. The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.
Sakorafas GH; Friess H; Peros G
Endocr Relat Cancer; 2008 Dec; 15(4):871-84. PubMed ID: 19015274
[TBL] [Abstract][Full Text] [Related]
25. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
[TBL] [Abstract][Full Text] [Related]
26. Surgical management of sporadic medullary thyroid cancer.
Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
[TBL] [Abstract][Full Text] [Related]
27. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
28. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
29. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.
Spinelli C; Strambi S; Rossi L; Elisei R; Massimino M
Curr Pediatr Rev; 2016; 12(4):280-285. PubMed ID: 27834132
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of medullary thyroid carcinoma.
Massoll N; Mazzaferri EL
Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
[TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid carcinoma.
Brauckhoff M; Lorenz K; Ukkat J; Brauckhoff K; Gimm O; Dralle H
Scand J Surg; 2004; 93(4):249-60. PubMed ID: 15658665
[TBL] [Abstract][Full Text] [Related]
32. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
33. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma.
Hamy A; Pessaux P; Mirallié E; Mucci-Hennekinne S; Gibelin H; Mor-Martinez C; de Calan L; Ronceray J; Kraimps JL
Eur J Surg Oncol; 2005 Sep; 31(7):774-7. PubMed ID: 15925476
[TBL] [Abstract][Full Text] [Related]
34. The surgical management of medullary thyroid cancer.
Dackiw AP
Otolaryngol Clin North Am; 2010 Apr; 43(2):365-74, ix. PubMed ID: 20510719
[TBL] [Abstract][Full Text] [Related]
35. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
Kebebew E; Kikuchi S; Duh QY; Clark OH
Arch Surg; 2000 Aug; 135(8):895-901. PubMed ID: 10922248
[TBL] [Abstract][Full Text] [Related]
37. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Quayle FJ; Moley JF
J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
[TBL] [Abstract][Full Text] [Related]
38. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
39. Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.
Schott M; Willenberg HS; Sagert C; Nguyen TB; Schinner S; Cohnen M; Cupisti K; Eisenberger CF; Knoefel WT; Scherbaum WA
Clin Endocrinol (Oxf); 2007 Mar; 66(3):405-9. PubMed ID: 17302876
[TBL] [Abstract][Full Text] [Related]
40. Current management of medullary thyroid cancer.
Milan SA; Sosa JA; Roman SA
Minerva Chir; 2010 Feb; 65(1):27-37. PubMed ID: 20212415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
